DEUTSCHE BANK AG\
BankPosition in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in CRNX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$9,353,306
-$1,586,780 QoQ
Shares Held
257,525
+9.6% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 65.53189010775652.ToString("F0")%
Shared 0.ToString("F0")%
None 34.46810989224347.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,467,737 across 247 Biotechnology names. CRNX ranks #39 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,353,306 | 257,525 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $10,940,086 | 235,018 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $9,678,002 | 232,365 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,613,836 | 195,196 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,846,251 | 204,122 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $10,804,484 | 211,314 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $11,043,577 | 216,117 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $9,132,187 | 203,889 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $3,258,302 | 69,607 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $2,861,591 | 80,427 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $898,444 | 30,210 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $415,991 | 23,085 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $615,402 | 38,319 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $535,402 | 29,257 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $422,671 | 21,521 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $465,559 | 24,963 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $577,130 | 26,293 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $831,588 | 29,271 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,895,678 | 90,056 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,679,270 | 89,086 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,298,280 | 84,966 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $288,845 | 20,471 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $241,740 | 15,427 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $247,399 | 14,121 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $55,829 | 3,798 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||